Skip to main content

Table 2 Characteristics of the study participants in the validation stage

From: Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals

Variables

NW(n = 20)

MUCO(29)

MHPO (30)

P1

P2

P3

Age (years)

44.9 ± 11.4

49.3 ± 11.4

43.4 ± 11.8

0.384

0.880

0.115

Sex (F/M)

10/10

15/14

15/15

1.000a

1.000a

1.000a

Anthropometry

      

 BMI (kg/m2)

21.7 ± 0.8

31.6 ± 3.2

30.1 ± 1.4

0.000

0.000

0.066

 Waist Circumference(cm)

80.7 ± 6.4

107.5 ± 9.5

92.1 ± 7.6

0.000

0.000

0.000

 BF %

25.3 ± 8.6

36.5 ± 6.9

35.6 ± 9.2

0.000

0.000

0.924

 TF %

26.9 ± 8.6

41.6 ± 5.8

39.8 ± 7.2

0.000

0.000

0.607

 AF%

31.9 ± 11.8

48.7 ± 5.7

45.9 ± 6.6

0.000

0.000

0.247

 Visceral fat(g)

354.3 ± 295.9

2077.8 ± 814.4

1120.00 ± 641.4

0.000

0.000

0.000

 VF%

2.5 ± 2.1

6.5 ± 2.3

4.2 ± 2.8

0.000

0.057

0.002

Metabolic Profile

      

 SBP (mmHg)

122.4 ± 14.4

137.4 ± 14.3

130.1 ± 15.9

0.003

0.192

0.165

 DBP (mmHg)

78.1 ± 9.3

84.3 ± 10.9

85.5 ± 8.3

0.072

0.028

0.890

 TG (mmol/L)

0.87 ± 0.29

2.79 ± 1.27

1.11 ± 0.53

0.000

0.060

0.000

 HDL-C (mmol/L)

1.6 ± 0.23

0.99 ± 0.17

1.5 ± 0.4

0.000

0.521

0.000

 Glucose (mmol/L)

5.0 ± 0.28

7.3 ± 2.8

4.9 ± 0.34

0.000

0.931

0.000

 Insulin (pmol/L)

38.9 ± 20.3

153.1 ± 48.6

58.5 ± 32.5

0.000

0.035

0.000

 HOMA-IR

1.2 ± 0.6

7.1 ± 3.9

1.9 ± 1.0

0.000

0.029

0.000

Diet and Physical Activity

      

 Caloric intake (kcal/day)

1896.2 ± 1199.7

1509.3 ± 568.2

1935.6 ± 789.5

0.292

0.999

0.210

 Protein intake (g/day)

65.8 ± 36.5

60.6 ± 32.7

73.1 ± 34.5

0.601

0.729

0.152

 Fat intake (g/day)

57.0 ± 22.7

50.2 ± 19.6

55.2 ± 20.4

0.800

0.984

0.863

 Carbohydrate (g/day)

238.6 ± 128.7

201.9 ± 87.1

248.9 ± 120.4

0.369

1.000

0.074

 Physical activity level

8.1 ± 1.7

7.3 ± 1.2

8.1 ± 1.4

0.090

0.974

0.089

  1. All values are means ± SDs. The One-Way ANCOVA followed by Tukey test was set to p < 0.05. NW: Normal Wight; MUCO: metabolically unhealthy central obesity; MHPO: metabolically healthy peripheral obesity; P1:The P value between MUCO and NW groups; P2:The P value between MHPO and NW groups; P3:The P value between MUCO and MHPO groups; Logarithmic transformation was used for the variables that did not have normal distribution (Insulin, glucose, HOMA-IR, TG)
  2. a Analyzed by chi-square tests by SPSS, statistical significance was set to p < 0.05